[The menopause and vascular risk].
The vascular risk associated with the administration of oestrogens is admitted by the majority, denied by some, and is extremely difficult to assess. As a matter of fact, no vascular accident seems to have been published up to the present day with menopausal women treated with natural oestrogens. The analysis of populations permits one to suppose in the absence of large scale prospective and comparative statistics, that a correct case-finding of risk-factors, and regular surveillance should permit the reduction to a minimum of the probability of vascular accidents.
Rozenbaum
H
H
D001161:Arteriosclerosis / Q000139:chemically induced / Q000503:physiopathology*; D004359:Drug Therapy, Combination; D045166:Estradiol Congeners / Q000009:adverse effects; D004967:Estrogens / Q000008:administration & dosage / Q000009:adverse effects*; D004966:Estrogens, Conjugated (USP) / Q000009:adverse effects; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D045167:Progesterone Congeners / Q000008:administration & dosage / Q000378:metabolism; D012306:Risk
D045166:Estradiol Congeners; D004967:Estrogens; D004966:Estrogens, Conjugated (USP); D045167:Progesterone Congeners
Ménopause et risque vasculaire.